Tricida, Inc. logo

Tricida, Inc.

Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its late-stage investigational product candidate, TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD).

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”TCDA” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.tricida.com
Founded2013
Disease Focus
Development Stage
STOCK CODENASDAQ: TCDA
Address
7000 Shoreline Court, Suite 201, CA 94080
San Francisco
United States
Email
Contact Number
+1 415-429-7800

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tricida-inc-” connections=”true” suffix=””]